BRADYKININ B-1 RECEPTORS IN RABBIT AORTA SMOOTH-MUSCLE CELLS IN CULTURE

被引:56
作者
SCHNECK, KA
HESS, JF
STONESIFER, GY
RANSOM, RW
机构
[1] MERCK SHARP & DOHME LTD,RES LABS,W POINT,PA 19486
[2] MERCK SHARP & DOHME LTD,RES LABS,RAHWAY,NJ 07065
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1994年 / 266卷 / 03期
关键词
BRADYKININ B-1 RECEPTOR; AORTA (RABBIT); SMOOTH MUSCLE CELL; DES-ARG(10)-KALLIDIN;
D O I
10.1016/0922-4106(94)90137-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kinin B-1 receptors on rabbit aorta smooth muscle cells in culture were investigated. [H-3]Des-Arg(10)-kallidin labeled a single site in cells at early passage with an equilibrium dissociation constant of 258 pM and a maximal binding density of approximately 680 sites/cell. Treatment of the same cells for 18 h with epidermal growth factor increased the binding density over 6-fold without affecting the ligand's affinity. At latter passages, the density of binding sites was found to increase and the growth factor had a much less pronounced effect. The rank order of potencies for agonist inhibition of binding (des-Arg(10)-kallidin > des-Arg(9)-BK = kallidin > bradykinin) was consistent with the specific labeling of a B-1 receptor. Also, [H-3]des-Arg(10)-kallidin binding was potently inhibited by the B-1 receptor antagonist des-Arg(9)[Leu(8)]bradykinin but not by the B-2 receptor antagonist Hoe 140. The agonists were found to stimulate phosphoinositide hydrolysis in the smooth muscle cells with an order of potencies that reflected their binding assay activities. Des-Arg(9)[Leu(8)] BK blocked the des-Arg(10)-kallidin response with a potency consistent with its known B-1 receptor activity while Hoe 140 was inactive. These results demonstrate the presence of inducible B-1 receptors on rabbit aorta smooth muscle cells in culture that couple to phospholipase C activation. These cells should be useful in future studies of the mechanisms and factors involved in the regulation of expression of the B-1 receptor.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 24 条
[1]   BINDING OF [H-3]-LABELED DES-ARG9-BK TO RABBIT ANTERIOR MESENTERIC VEIN [J].
BARABE, J ;
BABIUK, C ;
REGOLI, D .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1982, 60 (12) :1551-1555
[2]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[3]   STUDIES ON THE INDUCTION OF PHARMACOLOGICAL RESPONSES TO DES-ARG9-BRADYKININ INVITRO AND INVIVO [J].
BOUTHILLIER, J ;
DEBLOIS, D ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) :257-264
[4]   RECENT DEVELOPMENTS IN THE UNDERSTANDING OF BRADYKININ RECEPTORS [J].
BURCH, RM ;
KYLE, DJ .
LIFE SCIENCES, 1992, 50 (12) :829-838
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   SYNERGISM BETWEEN THE CONTRACTILE EFFECT OF EPIDERMAL GROWTH-FACTOR AND THAT OF DES-ARG9-BRADYKININ OR OF ALPHA-THROMBIN IN RABBIT AORTIC RINGS [J].
DEBLOIS, D ;
DRAPEAU, G ;
PETITCLERC, E ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :959-967
[7]   PHARMACOLOGICAL MODULATION OF THE UP-REGULATED RESPONSES TO DES-ARG9-BRADYKININ INVIVO AND INVITRO [J].
DEBLOIS, D ;
BOUTHILLIER, J ;
MARCEAU, F .
IMMUNOPHARMACOLOGY, 1989, 17 (03) :187-198
[8]   AN ENZYME IN HUMAN BLOOD PLASMA THAT INACTIVATES BRADYKININ AND KALLIDINS [J].
ERDOS, EG ;
SLOANE, EM .
BIOCHEMICAL PHARMACOLOGY, 1962, 11 (JUL) :585-+
[9]   CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN BRADYKININ (BK-2) RECEPTOR [J].
HESS, JF ;
BORKOWSKI, JA ;
YOUNG, GS ;
STRADER, CD ;
RANSOM, RW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (01) :260-268
[10]   PHARMACOLOGY OF KININS - THEIR RELEVANCE TO TISSUE-INJURY AND INFLAMMATION [J].
MARCEAU, F ;
LUSSIER, A ;
REGOLI, D ;
GIROUD, JP .
GENERAL PHARMACOLOGY, 1983, 14 (02) :209-229